Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System
NCT02362386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17
Last updated 2016-04-05
Summary
The objective of the study is to assess the logistical and biological feasibility of preparing ADRCs from adipose tissue excised during standard-of-care burn wound excision using the Celution® System for autologous, same-day application to the burn wound.
Conditions
- Thermal Burn
Interventions
- DEVICE
-
Celution Device
Non-interventional evaluation of Celution Device preparation of ADRCs from thermal burn eschar tissue that would normally be discarded.
Sponsors & Collaborators
-
Cytori Therapeutics
lead INDUSTRY
Principal Investigators
-
Steven Kesten, MD · Cytori Therapeutics, Inc.
Eligibility
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2016-02-29
- Completion
- 2016-02-29
Countries
- United States
Study Locations
More Related Trials
-
CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
NCT02994654 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
NCT06223269 ·Status: RECRUITING ·Phase: PHASE3
-
Adipose-derived Stem Cells to Treat Chronic Wounds.
NCT05797688 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries
NCT01138917 ·Status: COMPLETED ·Phase: NA
-
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
NCT01437852 ·Status: COMPLETED ·Phase: PHASE1
-
Biological Skin Graft With Keratinocyte-stem Cell Co-cultre for Burn Patients
NCT05652816 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Microsurfaced Grafts in Deep Burn Wounds
NCT04589442 ·Status: RECRUITING ·Phase: PHASE4
-
ST266 Versus Standard Care In Treating Partial Thickness Burns
NCT00886470 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Efficacy Of Autologous Epidermal Cell Suspension And Silver Sulfadiazine Ointment In Burn
NCT03162367 ·Status: COMPLETED ·Phase: PHASE2
-
Continued Access to the Recell® Device for Treatment of Acute Burn Injuries
NCT03333941 ·Status: COMPLETED
-
Factors That Influence Adipose Derived Regenerative Cells' Yield and Viability
NCT02651233 ·Status: COMPLETED
-
An Acellular Epithelial Skin Substitute in Deep Partial-thickness Burns
NCT01454310 ·Status: COMPLETED ·Phase: PHASE4
-
Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
NCT03227146 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Adult Stem Cell Response to Burn Injury
NCT00609661 ·Status: WITHDRAWN
-
Autologous Keratinocyte Suspension Versus Adipose-Derived Stem Cell-Keratinocyte Suspension for Post-Burn Raw Area
NCT03686449 ·Status: UNKNOWN ·Phase: NA
-
Stem Cell Therapy to Improve Burn Wound Healing
NCT02104713 ·Status: COMPLETED ·Phase: PHASE1
-
Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts
NCT01715012 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases
NCT02992249 ·Status: COMPLETED
-
Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique
NCT02982096 ·Status: COMPLETED ·Phase: NA
-
StrataGraft Safety, Tolerability and Efficacy in Pediatric Subjects
NCT05517902 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
NCT06745557 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Safety and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe Burn Wounds
NCT03695939 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs)
NCT03113747 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds
NCT01655407 ·Status: UNKNOWN ·Phase: PHASE2
-
Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Residual Burn Wound
NCT04235296 ·Status: UNKNOWN ·Phase: PHASE1